Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Wound Healing and Aging in a Burn Model
FY 2021-22
Summary
Despite recent advances in burn care, elderly patients continue to experience the highest mortality and morbidity rates after burn injuries. While the exact reasons are unknown, recent studies have linked these worsened outcomes to impaired wound healing in older burn patients. With aging, cells lose their ability to divide and interestingly this is implicated in both wound healing and tissue repair. These non-dividing, otherwise known as senescent cells, release several inflammatory molecules which induce local and systemic dysfunction. While short-lived senescence is required for mild wounds, the long-lived accumulation of senescent cells places a burden on more severe wounds such as burns, slowing the healing process and speeding up disease progression. To target these accumulating cells, recent research has discovered senolytic drugs, a class of drugs that selectively kill senescent cells. Among these drugs are Dasatinib plus Quercetin (D+Q) which hold great potential as they are being used in clinical trials for multiple age-related human diseases. The purpose of this research is to investigate the mechanisms underlying impaired wound healing to pave the way for effective therapies that can improve outcomes for this highly vulnerable population. We hypothesize that D+Q will improve post-burn wound healing outcomes in the elderly by effectively reducing senescent cells, allowing normal tissue repair. As the elderly population continues to grow, there is an immense need for aging studies. With clinical trials for adults burn patients in progress, it is crucial that we investigate novel strategies that will provide mechanisms understanding these poor outcomes in the elderly, and allow us to ultimately proceed with caution to upcoming clinical trials.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
466897
Name
Faour Sara
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Wound Healing and Aging in a Burn Model
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aging; Burn; Cellular Senescence; Chronic Wounds; Dendritic Cells; Endothelial Cells; Fibroblasts; Keratinocytes; Langerhan Cells; Macrophages; Senescence-Associated Secretory Phenotype; Senolytic Drugs; Stem Cell Exhaustion; T Cells; Wound Healing
Abstract
Despite recent advances in burn care, elderly patients continue to experience the highest mortality and morbidity rates after burn injuries. While the exact reasons are unknown, recent studies have linked these worsened outcomes to impaired wound healing in older burn patients. With aging, cells lose their ability to divide and interestingly this is implicated in both wound healing and tissue repair. These non-dividing, otherwise known as senescent cells, release several inflammatory molecules which induce local and systemic dysfunction. While short-lived senescence is required for mild wounds, the long-lived accumulation of senescent cells places a burden on more severe wounds such as burns, slowing the healing process and speeding up disease progression. To target these accumulating cells, recent research has discovered senolytic drugs, a class of drugs that selectively kill senescent cells. Among these drugs are Dasatinib plus Quercetin (D+Q) which hold great potential as they are being used in clinical trials for multiple age-related human diseases. The purpose of this research is to investigate the mechanisms underlying impaired wound healing to pave the way for effective therapies that can improve outcomes for this highly vulnerable population. We hypothesize that D+Q will improve post-burn wound healing outcomes in the elderly by effectively reducing senescent cells, allowing normal tissue repair. As the elderly population continues to grow, there is an immense need for aging studies. With clinical trials for adults burn patients in progress, it is crucial that we investigate novel strategies that will provide mechanisms understanding these poor outcomes in the elderly, and allow us to ultimately proceed with caution to upcoming clinical trials.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Faour, Sara
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~